Table 4.
Relative abundance alterations of C. butyricum after eradication treatment.
| Relative abundance (%) |
|||||
|---|---|---|---|---|---|
| Group A | Group B | Group C | P1 | P2 | |
| Day 0 | 0.000257 | 0.005076 | 0.000106 | 0.179 | 0.070 |
| Day 14 | 0.003032 | 1.241000 | 0.025 | 0.001 | |
| Day 56 | 0.001224 | 0.122200 | 0.371 | 0.168 | |
| P3 | 0.612 | 0.096 | |||
| P4 | 0.958 | 0.801 | |||
Group A, H. pylori-infected patients treated with bismuth-containing quadruple therapy; Group B, H. pylori-infected patients treated with bismuth-containing quadruple therapy and supplemented with C. butyricum; Group C, H. pylori-negative participants.
P1, p values of difference between group A and group B.
P2, p values of difference among group A, group B and group C.
P3, p values of difference between day 0 and day 14.
P4, p values of difference between day 0 and day 56.